Vox Markets Logo

London pre-open: Stocks to fall as Sunak set to reveal support package

06:29, 24th September 2020

(Sharecast News) - London stocks were set to fall at the open on Thursday amid ongoing worries about rising Covid-19 infections, as investors await details on the measures Chancellor Rishi Sunak will implement to replace the furlough scheme.
The FTSE 100 was called to open 50 points lower at 5,849.

CMC Markets analyst Michael Hewson said: "Yesterday Chancellor of the Exchequer Rishi Sunak announced that the budget that was expected to take place next month has been cancelled, as he and the Treasury look to embark on a new plan of measures, that will allow the businesses most affected by the virus, to keep working.

"It now seems likely that he will finish the furlough scheme, however it is more than likely to be replaced by another type of plan, more suited to the requirements of smaller and more medium sized businesses, as we gear up for a long hard haul toward March 2021.

"Details of the shape and scope of this new support scheme are expected to be announced later today, with speculation about wage subsidies and targeted aid on the more exposed sectors, in order to keep these businesses on life support, until some sort of normalisation."

Market participants will also be eyeing a speech by Bank of England governor Andrew Bailey later in the day, particularly after his comments earlier in the week about negative interest rates.

In corporate news, Smiths Group reinstated its dividend as the company said business was stabilising after a sharp drop in annual profit.

Statutory operating profit fell 26% to £241m in the year to the end of July as revenue rose 2% to £2.55bn. Headline operating profit fell 11% to £382m.

After declaring no interim dividend in March Smiths proposed a total dividend for the year of 35p per share, down from 45.9p a year earlier. The company said the payout reflected its strong performance and confidence about the future. It said trends had stabilised and group underlying revenue was down 5% in the past four months.

Harvester and All Bar One owner Mitchells & Butlers said like-for-like sales had fallen 3.1% so far in its fiscal year as it warned of a "challenging and uncertain" future after the UK government imposed new Covid-19 restrictions on the hospitality industry.

The pub and restaurant owner said sales plunged by a third in July and had bounced back during August's 'Eat-out-to-help-out' discount scheme before settling at a 6.4% decline this month before the new curbs were announced.

It added that it had unsecured cash balances of around £100m, in addition to undrawn committed unsecured facilities of £140m.

"The future remains both challenging and uncertain, with only this week a curfew and other additional restrictions being imposed on how and when we can operate. However, we believe we are well placed to meet that challenge and to keep Mitchells & Butlers at the forefront of the eating and drinking-out market," said chief executive Phil Urban.

TwitterFacebookLinkedIn

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Recent Articles
  • London close: Stocks rise as US payrolls come in weaker

    2 hours ago

    London markets closed positively on Friday, as investors digested slower-than-expected payrolls growth in the US, while Anglo American jumped amid anticipation of a potential bidding war for the mining giant.

  • FTSE 250 movers: Trainline rolling; Georgia banks out of favour

    2 hours ago

    FTSE 250 (MCX) 20,198.09 0.73%

  • FTSE 100 movers: Anglo rallies on Reuters report; IHG slumps

    2 hours ago

    London's FTSE 100 was up 0.5% at 8,209.34 in afternoon trade on Friday.

  • Berenberg raises target price on Standard Chartered

    4 hours ago

    Analysts at Berenberg raised their target price on multinational bank Standard Chartered from 1,050.0p to 1,100.0p on Friday after the group's Q1 earnings "validated" management's suggestion that the bank had experienced "an encouraging start" to the year.

  • Citi sees significant upside at Team17

    4 hours ago

    Citi has reiterated its 'buy' rating for British video-game developer Team17, saying it sees significant upside to its valuation as operations stabilise.

  • Jefferies downgrades AJ Bell after share price rally

    4 hours ago

    Jefferies downgraded its stance on AJ Bell on Friday to 'hold' from 'buy' after a circa 30% rally in the shares this year.

  • Triple Point to sell part of portfolio after shareholder consultation

    4 hours ago

    Triple Point Social Housing announced plans to sell part of its portfolio on Friday, following shareholder consultations.

  • Adriatic Metals announces resignation of CFO

    4 hours ago

    Adriatic Metals, the FTSE 250 precious and base metals miner, has announced that its chief financial officer is stepping down after just two years on the job.

  • CMA set for deeper probe of Pennon's SES acquisition

    4 hours ago

    Pennon Group worked to assure the market that its acquisition of Sutton and East Surrey Water (SES Water) would avoid a deeper competition probe on Friday, telling shareholders that it planned to offer "appropriate undertakings" to regulators.

  • Angle strikes supplier deal with AstraZeneca

    4 hours ago

    Liquid biopsy technology firm Angle has struck a supplier deal with pharmaceutical giant AstraZeneca to develop an androgen receptor detection assay to enhance prostate cancer studies.

Watchlist